The clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens

scientific article published on 14 February 2012

The clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/AJG.2011.387
P8608Fatcat IDrelease_cyhdpuczlrg2zn677k643zhdpi
P698PubMed publication ID22334249

P2093author name stringCheol-In Kang
Kyu Taek Lee
Jong Kyun Lee
Kwang Hyuck Lee
Young Kyung Sung
P2860cites workEmergency surgery for severe acute cholangitis. The high-risk patientsQ24540384
Acute cholangitis. Multivariate analysis of risk factorsQ24550551
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of AmericaQ28268745
Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentaryQ33540823
Acute (ascending) cholangitis.Q34033188
Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcomeQ34106854
Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcomeQ34351978
The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and CandidaQ34666332
Intra-abdominal Sepsis in Elderly PersonsQ34681098
Acute biliary septic shockQ36712023
Diagnostic criteria and severity assessment of acute cholangitis: Tokyo GuidelinesQ36718098
Clinical significance of extended-spectrum beta-lactamases.Q37291354
Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes.Q37361423
Antibiotics in the treatment of biliary infectionQ40184576
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of AmericaQ41445493
Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniaeQ42167308
Bloodstream infections caused by ESBL-producing E. coli and K. pneumoniae: risk factors for multidrug-resistanceQ43065214
In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).Q44007271
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomesQ44436393
Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcomeQ45097000
Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcomeQ46173410
Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients.Q46257399
Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalizationQ49046570
Septicemia from biliary tract infectionQ50159216
Epidemiology and prognostic determinants of patients with bacteremic cholecystitis or cholangitis.Q50162196
Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria.Q51051228
Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli.Q54381514
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectclinical epidemiologyQ5834738
P304page(s)473-483
P577publication date2012-02-14
P1433published inThe American Journal of GastroenterologyQ7713501
P1476titleThe clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens
P478volume107

Reverse relations

cites work (P2860)
Q33851181A Patient Presenting with Cholangitis due to Stenotrophomonas Maltophilia and Pseudomonas Aeruginosa Successfully Treated with Intrabiliary Colistine
Q26782881Acute Bacterial Cholangitis
Q39723374Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis
Q55362422Anaerobic coverage as definitive therapy does not affect clinical outcomes in community-onset bacteremic biliary tract infection without anaerobic bacteremia.
Q37192102Antimicrobial resistance in Asia: current epidemiology and clinical implications
Q33735481Appendectomy as a Risk Factor for Bacteremic Biliary Tract Infection Caused by Antibiotic-Resistant Pathogens
Q26780350Calculated Antibiosis of Acute Cholangitis and Cholecystitis
Q93048752Clinical epidemiology and outcomes of biliary tract infections caused by Klebsiella pneumoniae
Q43719510Clinical impact of inappropriate initial antimicrobial therapy on outcome in bacteremic biliary tract infections
Q37607641Determination of antibiotic consumption index for animal originated foods produced in animal husbandry in Iran, 2010
Q57106909Etiologies, risk factors, and outcomes of bacterial cholangitis after living donor liver transplantation
Q90086575Guidelines for Antibiotic Prescription in Intensive Care Unit
Q89681409Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis
Q92668877Pathophysiologic Characterization of a Novel Rabbit Model of Biliary Tract Infection-Derived Sepsis
Q92735381Shortening antibiotic duration in the treatment of acute cholangitis: rationale and study protocol for an open-label randomized controlled trial
Q42277917TG13 antimicrobial therapy for acute cholangitis and cholecystitis
Q46770277Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.
Q38735828Updated comprehensive epidemiology, microbiology, and outcomes among patients with acute cholangitis